$1.93 Billion is the total value of Novo Holdings A/S's 49 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 20.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDStotal stk mkt | $429,442,000 | -0.3% | 1,933,900 | 0.0% | 22.21% | +16.2% | |
| BAM | Buy | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $165,516,000 | +5.6% | 3,093,171 | +0.6% | 8.56% | +23.1% |
| BSX | New | BOSTON SCIENTIFIC CORP | $150,285,000 | – | 3,463,577 | +100.0% | 7.77% | – |
| AAPL | APPLE INC | $146,793,000 | +3.3% | 1,037,404 | 0.0% | 7.59% | +20.5% | |
| MORF | Sell | MORPHIC HLDG INC | $116,137,000 | -23.5% | 2,050,446 | -22.5% | 6.01% | -10.8% |
| EWTX | EDGEWISE THERAPEUTICS INC | $92,748,000 | -22.2% | 5,587,207 | 0.0% | 4.80% | -9.3% | |
| CYT | CYTEIR THERAPEUTICS INC | $84,949,000 | -18.0% | 4,840,413 | 0.0% | 4.39% | -4.4% | |
| NKTX | NKARTA INC | $77,697,000 | -12.2% | 2,793,864 | 0.0% | 4.02% | +2.3% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $56,975,000 | -18.2% | 4,503,991 | 0.0% | 2.95% | -4.6% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $48,707,000 | +15.2% | 2,445,147 | 0.0% | 2.52% | +34.3% | |
| INGN | Sell | INOGEN INC | $46,508,000 | -65.7% | 1,079,320 | -48.1% | 2.41% | -60.0% |
| ALGS | ALIGOS THERAPEUTICS INC | $40,552,000 | -23.9% | 2,614,563 | 0.0% | 2.10% | -11.3% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $31,805,000 | -44.5% | 214,827 | 0.0% | 1.64% | -35.3% | |
| CABO | Sell | CABLE ONE INC | $28,780,000 | -41.9% | 15,873 | -38.7% | 1.49% | -32.2% |
| VERV | Sell | VERVE THERAPEUTICS INC | $28,200,000 | -41.0% | 600,000 | -24.4% | 1.46% | -31.2% |
| VECT | VECTIVBIO HLDG AG | $27,190,000 | -33.8% | 3,522,019 | 0.0% | 1.41% | -22.8% | |
| SPRB | SPRUCE BIOSCIENCES INC | $27,131,000 | -46.4% | 4,514,336 | 0.0% | 1.40% | -37.5% | |
| RPHM | RENEO PHARMACEUTICALS INC | $25,556,000 | -20.1% | 3,430,377 | 0.0% | 1.32% | -6.9% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $24,450,000 | +26.9% | 2,560,211 | +28.1% | 1.26% | +48.1% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $20,629,000 | +17.4% | 836,518 | +23.9% | 1.07% | +37.0% |
| BPMC | BLUEPRINT MEDICINES CORP | $20,254,000 | +16.9% | 197,000 | 0.0% | 1.05% | +36.3% | |
| GRTX | GALERA THERAPEUTICS INC | $19,918,000 | -17.6% | 2,459,021 | 0.0% | 1.03% | -3.9% | |
| LVTX | LAVA THERAPEUTICS NV | $19,698,000 | -45.6% | 3,327,312 | 0.0% | 1.02% | -36.6% | |
| INSM | INSMED INC | $19,163,000 | -3.2% | 695,840 | 0.0% | 0.99% | +12.9% | |
| SPNE | Sell | SEASPINE HLDGS CORP | $17,295,000 | -24.3% | 1,099,478 | -1.3% | 0.90% | -11.6% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $15,964,000 | – | 534,085 | +100.0% | 0.83% | – |
| MIST | MILESTONE PHARMACEUTICALS IN | $14,450,000 | +3.8% | 2,530,585 | 0.0% | 0.75% | +21.1% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $11,476,000 | +64.3% | 498,528 | +66.2% | 0.59% | +91.6% |
| GLTO | GALECTO INC | $8,967,000 | -29.1% | 2,497,791 | 0.0% | 0.46% | -17.3% | |
| LUNG | Buy | PULMONX CORP | $8,889,000 | +7.7% | 247,047 | +32.1% | 0.46% | +25.7% |
| SPRO | SPERO THERAPEUTICS INC | $8,632,000 | +31.9% | 468,902 | 0.0% | 0.45% | +53.8% | |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $8,615,000 | -33.4% | 2,170,100 | 0.0% | 0.45% | -22.3% | |
| FLXN | FLEXION THERAPEUTICS INC | $8,561,000 | -25.9% | 1,403,370 | 0.0% | 0.44% | -13.5% | |
| AKUS | Buy | AKOUOS INC | $8,266,000 | +43.4% | 711,945 | +55.0% | 0.43% | +67.2% |
| SILK | SILK RD MED INC | $8,120,000 | +15.0% | 147,557 | 0.0% | 0.42% | +34.2% | |
| TMCI | Sell | TREACE MED CONCEPTS INC | $7,633,000 | -24.4% | 283,769 | -12.1% | 0.40% | -11.8% |
| PHVS | Buy | PHARVARIS N V | $7,428,000 | +258.7% | 418,943 | +276.9% | 0.38% | +317.4% |
| ZGNX | ZOGENIX INC | $6,722,000 | -12.1% | 442,550 | 0.0% | 0.35% | +2.7% | |
| FRLN | Sell | FREELINE THERAPEUTICS HLDGSsponsored ads | $6,575,000 | -65.8% | 1,928,157 | -18.3% | 0.34% | -60.2% |
| AERI | AERIE PHARMACEUTICALS INC | $6,329,000 | -28.8% | 555,186 | 0.0% | 0.33% | -17.0% | |
| NARI | INARI MED INC | $5,856,000 | -13.1% | 72,212 | 0.0% | 0.30% | +1.3% | |
| INSP | Sell | INSPIRE MED SYS INC | $4,960,000 | -44.4% | 21,300 | -53.8% | 0.26% | -35.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $4,720,000 | -19.7% | 25,000 | -27.9% | 0.24% | -6.5% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $4,623,000 | -72.2% | 250,000 | -72.5% | 0.24% | -67.6% |
| VRNA | VERONA PHARMA PLCsponsored ads | $4,171,000 | -16.2% | 761,205 | 0.0% | 0.22% | -2.3% | |
| AFIB | ACUTUS MED INC | $2,254,000 | -47.9% | 255,000 | 0.0% | 0.12% | -39.1% | |
| ANNX | New | ANNEXON INC | $2,128,000 | – | 114,330 | +100.0% | 0.11% | – |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $1,533,000 | -96.2% | 40,000 | -97.2% | 0.08% | -95.6% |
| FSTX | F-STAR THERAPEUTICS INC | $20,000 | -13.0% | 2,703 | 0.0% | 0.00% | 0.0% | |
| BAMR | Exit | BROOKFIELD ASSET MGMT REINScl a exch lt vtg | $0 | – | -21,179 | -100.0% | -0.05% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -53,300 | -100.0% | -0.23% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -508,922 | -100.0% | -0.39% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -422,382 | -100.0% | -0.41% | – |
| EAR | Exit | EARGO INC | $0 | – | -237,071 | -100.0% | -0.42% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -279,676 | -100.0% | -0.51% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -600,010 | -100.0% | -1.19% | – |
| INZY | Exit | INOZYME PHARMA INC | $0 | – | -1,867,706 | -100.0% | -1.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.